https://www.sioltatherapeutics.com/press/news-publications/maturation-of-the-gut-microbiome-and-risk-of-asthma-in-childhood/https://www.sioltatherapeutics.com/press/news-publications/early-infancy-microbial-and-metabolic-alterations-affect-risk-of-childhood-asthma/https://www.sioltatherapeutics.com/press/news-publications/temporal-development-of-the-gut-microbiome-in-early-childhood-from-the-teddy-study/https://www.sioltatherapeutics.com/press/news-publications/humans-as-holobiots-implications-for-prevention-and-therapy/https://www.sioltatherapeutics.com/press/news-publications/allergic-diseases-and-asthma-a-global-public-health-concern-and-a-call-to-action-8/https://www.sioltatherapeutics.com/press/news-publications/association-between-use-of-acid-suppressive-medications-and-antibiotics-during-infancy-and-allergic-diseases-in-early-childhood/https://www.sioltatherapeutics.com/press/news-publications/the-human-intestinal-microbiome-in-health-and-disease/https://www.sioltatherapeutics.com/press/news-publications/delayed-gut-microbiota-development-in-high-risk-for-asthma-infants-is-temporarily-modifiable-by-lactobacillus-supplementation/https://www.sioltatherapeutics.com/press/news-publications/neonatal-gut-microbota-associates-with-childhood-multisensitized-atopy-and-t-cell-differentiation/https://www.sioltatherapeutics.com/press/news-publications/biocentury/https://www.sioltatherapeutics.com/press/news-publications/precision-medicine-world-conference-2018/https://www.sioltatherapeutics.com/press/news-publications/gen-magazine/https://www.sioltatherapeutics.com/press/news-publications/microbiota-in-allergy-and-asthma-and-the-emerging-relationship-with-the-gut-microbiome/https://www.sioltatherapeutics.com/press/news-publications/bill-melinda-gates-foundation-grand-challenges-explorations/https://www.sioltatherapeutics.com/press/news-publications/community-ecology-as-a-framework-for-human-microbiome-research/https://www.sioltatherapeutics.com/press/news-publications/effects-of-microbiota-directed-foods-in-gnotobiotic-animals-and-undernourished-children/https://www.sioltatherapeutics.com/press/news-publications/microbiome-therapeutic-innovation-group-mtig/https://www.sioltatherapeutics.com/press/news-publications/3rd-annual-biotech-week-at-sfusd/https://www.sioltatherapeutics.com/press/news-publications/elevated-faecal-1213-dihome-concentration-in-neonates-at-high-risk-for-asthma-is-produced-by-gut-bacteria-and-impedes-immune-tolerance/https://www.sioltatherapeutics.com/press/news-publications/elevated-faecal-1213-dihome-concentration-in-neonates-at-high-risk-for-asthma-is-produced-by-gut-bacteria-and-impedes-immune-tolerance-2/https://www.sioltatherapeutics.com/press/news-publications/welcome-to-dr-john-martin-former-ceo-chairperson-of-gilead/https://www.sioltatherapeutics.com/press/news-publications/fast-track-designation/https://www.sioltatherapeutics.com/press/news-publications/series-b-30-million/https://www.sioltatherapeutics.com/press/news-publications/microbiome-based-prognostics-for-early-identification-of-allergy-and-asthma/https://www.sioltatherapeutics.com/press/news-publications/advance-technology-small-business-innovation-grant-award-from-niaid/https://www.sioltatherapeutics.com/press/news-publications/finding-the-right-fit-evaluation-of-short-read-and-long-read-sequencing-approaches-to-maximize-the-utility-of-clinical-microbiome-data/https://www.sioltatherapeutics.com/press/news-publications/siolta-initiates-dosing-in-newborn-subjects-in-a-groundbreaking-trial-of-stmc-103h/https://www.sioltatherapeutics.com/press/news-publications/series-c-12-million/